Similar articles

• Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.

  Law MG, Batey RG. Law MG, et al. Med J Aust. 2003 Mar 3;178(5):197-8. Med J Aust. 2003. PMID: 12603178 No abstract available.
• [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].

  Takács IG, Demetrovics Z. Takács IG, et al. Psychiatr Hung. 2009;24(4):264-81. Psychiatr Hung. 2009. PMID: 19949245 Review. Hungarian.
• Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.

  Amundsen EJ. Amundsen EJ. Addiction. 2006 Jul;101(7):911-2. doi: 10.1111/j.1360-0443.2006.01519.x. Addiction. 2006. PMID: 16771880 No abstract available.
• Injecting drug use in India and the need for policy and program change.

  Panda S, Kumar MS. Panda S, et al. Int J Drug Policy. 2016 Nov;37:115-116. doi: 10.1016/j.drugpo.2016.08.009. Epub 2016 Oct 20. Int J Drug Policy. 2016. PMID: 27771524 No abstract available.
• Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

  Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Birkhead GS, et al. Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20. Int J Drug Policy. 2007. PMID: 17854731 Review.